Fundraising FoxNext Frontier Biosciences
Boulder, US · Founded 2014 · Delaware corporation
Find your way into Next Frontier Biosciences
Sign up to see every warm intro you have to Next Frontier Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Next Frontier Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Reported raises · per SEC filings
Form D private placements$8.7M disclosed across 6 rounds · 2014–2020
▶$825.6KraisedJan 2020 · 27 investors · Other Health CareRule 506(b)
▶$825.6KraisedJan 2020 · 27 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Peter JohnsonPromoter
- Paul JohnsonDirector
- Charles SanderDirector
- James KreitmanDirector
- Marc GraboyesExecutive Officer, Director, Promoter
- Offering amount
- $1.2M
- Amount sold
- $825.6K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$2.9MraisedJan 2019 · 20 investors · Other Health CareRule 506(b)
▶$2.9MraisedJan 2019 · 20 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc GraboyesExecutive Officer, Director
- Paul JohnsonExecutive Officer, Director
- Offering amount
- $3.2M
- Amount sold
- $2.9M
- First sale
- Aug 2017
- Incorporated
- Limited Liability Company, Colorado, 2014
- Federal exemptions
- 06b
▶$1.8MraisedMay 2017 · 14 investors · Other Health CareRule 506(b)
▶$1.8MraisedMay 2017 · 14 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc GraboyesExecutive Officer, Director
- Paul JohnsonExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.8M
- Sales commissions
- $120K
- Placement agents
- LoHi Securities
- First sale
- Mar 2017
- Incorporated
- Limited Liability Company, Colorado, 2014
- Federal exemptions
- 06b
▶$850KraisedOct 2016 · 4 investors · Other Health CareRule 506(b)
▶$850KraisedOct 2016 · 4 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc GraboyesExecutive Officer, Director
- Paul JohnsonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $850K
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Colorado, 2014
- Federal exemptions
- 06b
▶$1.3MraisedApr 2016 · 22 investors · Other Health CareRule 506(b)
▶$1.3MraisedApr 2016 · 22 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Marc GraboyesExecutive Officer, Director
- Paul JohnsonExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.3M
- First sale
- Aug 2015
- Incorporated
- Limited Liability Company, Colorado, 2014
- Federal exemptions
- 06b
▶$1.1MraisedDec 2014 · 12 investors · Other Health CareRule 506(b)
▶$1.1MraisedDec 2014 · 12 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul JohnsonExecutive Officer, Director
- Marc GraboyesExecutive Officer, Director
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- Minimum investment
- $10K
- First sale
- Dec 2014
- Incorporated
- Limited Liability Company, Colorado, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Next Frontier Biosciences raised?
- Next Frontier Biosciences has disclosed $8.7M raised across 6 rounds.
- Where is Next Frontier Biosciences headquartered?
- Next Frontier Biosciences is headquartered in Boulder, US.